These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 10409521)

  • 1. Matching treatment to the genetic basis of (lipid) disorder in patients with coronary artery disease.
    Jukema JW
    Heart; 1999 Aug; 82(2):126-7. PubMed ID: 10409521
    [No Abstract]   [Full Text] [Related]  

  • 2. Tailored therapy to fit individual profiles. Genetics and coronary artery disease.
    Jukema JW; Kastelein JJ
    Ann N Y Acad Sci; 2000 May; 902():17-24; discussion 24-6. PubMed ID: 10865822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of two genetic variations of lipoprotein lipase, S447X and Hind III, with coronary artery disease and hypertriglyceridemia.
    Pasalić D; Ferencak G; Grsković B; Sesto M; Stavljenić-Rukavina A
    Coll Antropol; 2006 Sep; 30(3):549-54. PubMed ID: 17058522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of PvuII polymorphism in the lipoprotein lipase gene with the coronary artery disease in Macedonian population.
    Georgiev A; Panov S; Sadikario S
    Prilozi; 2008 Dec; 29(2):213-25. PubMed ID: 19259048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Genetic factors in myocardial infarction--Results from a candidate gene and a genome-wide approach between beta blockers].
    Hengstenberg C; Bröckel U; Holmer S; Mayer B; Fischer M; Baessler A; Erdmann J; Lieb W; Löwel H; Riegger G; Schunkert H
    Herz; 2002 Nov; 27(7):649-61. PubMed ID: 12439636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms, lipoproteins and coronary artery disease risk.
    Talmud PJ; Humphries SE
    Curr Opin Lipidol; 2001 Aug; 12(4):405-9. PubMed ID: 11507325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein lipase gene variants and coronary risk.
    Fumeron F; Jemaa R; Poirier O; Cambien F; Tiret L
    Circulation; 1998 Jun; 97(25):2588. PubMed ID: 9657485
    [No Abstract]   [Full Text] [Related]  

  • 8. [Anti-atherogenic drugs].
    Kanaki T; Saito Y
    Nihon Rinsho; 1998 Oct; 56(10):2635-9. PubMed ID: 9796331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. To intervene or not in transplanted coronary artery disease.
    Mooney MR
    J Invasive Cardiol; 2000 Jun; 12(6):316. PubMed ID: 10859718
    [No Abstract]   [Full Text] [Related]  

  • 10. [ESTIMATING THE EFFECTIVENESS OF HYPOLIPIDEMIC THERAPY WITH ROSUVASTATIN IN PATIENTS WITH CORONARY HEART DISEASE DEPENDING ON THE GENOTYPE OF LIPOPROTEIN LIPASE].
    Zvyagina MV; Mal GS; Bushueva OY; Alymenko MA; Bykanova MA; Letova IM; Gribovskaya IA; Churnosov MI; Solodilova MA; Polonikov AV
    Eksp Klin Farmakol; 2016; 79(1):15-9. PubMed ID: 27159952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAI-1 and homocysteine, but not lipoprotein (a) and thrombophilic polymorphisms, are independently associated with the occurrence of major adverse cardiac events after successful coronary stenting.
    Marcucci R; Brogi D; Sofi F; Giglioli C; Valente S; Liotta AA; Lenti M; Gori AM; Prisco D; Abbate R; Gensini GF
    Heart; 2006 Mar; 92(3):377-81. PubMed ID: 15994914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary artery disease and diabetes.
    Rutter MK; Marshall SM; McComb JM
    Heart; 1997 Dec; 78(6):527-8. PubMed ID: 9470860
    [No Abstract]   [Full Text] [Related]  

  • 13. The low down on lipoprotein lipase.
    Funke H; Assmann G
    Nat Genet; 1995 May; 10(1):6-7. PubMed ID: 7647792
    [No Abstract]   [Full Text] [Related]  

  • 14. Common genetic variants that relate to disorders of lipid transport in Spanish subjects with premature coronary artery disease.
    Masana L; Febrer G; Cavanna J; Baroni MG; Marz W; Hoffmann MM; Shine B; Galton DJ
    Clin Sci (Lond); 2001 Feb; 100(2):183-90. PubMed ID: 11171287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between the ACE genotype and coronary artery disease. Insights from studies on restenosis, vasomotion and thrombosis.
    Bauters C; Amouyel P
    Eur Heart J; 1998 Sep; 19 Suppl J():J24-9. PubMed ID: 9796837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACE gene polymorphism and coronary restenosis.
    Bauters C; Amouyel P; Bertrand ME
    Semin Interv Cardiol; 1999 Sep; 4(3):145-9. PubMed ID: 10545620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary artery disease: Risk stratification and patient selection for more aggressive secondary prevention.
    Schiele F; Ecarnot F; Chopard R
    Eur J Prev Cardiol; 2017 Jun; 24(3_suppl):88-100. PubMed ID: 28618915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are polymorphisms in the ACE gene a potent genetic risk factor for restenosis?
    Kaski JC
    Br Heart J; 1994 Aug; 72(2):101. PubMed ID: 7917678
    [No Abstract]   [Full Text] [Related]  

  • 19. [Association between variants of lipoprotein lipase and coronary heart disease in a Tunisian population].
    Jelassi A; Jguirim I; Slimani A; Najah M; Hamda KB; Addad F; Hassine M; Maatouk F; Varret M; Slimane MN
    Pathol Biol (Paris); 2012 Jun; 60(3):180-4. PubMed ID: 21621348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between lipoprotein lipase gene polymorphisms and insulin resistance in coronary heart disease.
    Lee WJ; Sheu WH; Jeng CY; Young MS; Chen YT
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jul; 63(7):563-72. PubMed ID: 10934810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.